You have 9 free searches left this month | for more free features.

adenocarcinoma of the prostate

Showing 51 - 75 of 8,290

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer, Adenocarcinoma, Prostatic Tumors Trial (bpMRI, Image-Fusion targeted and systematic Biopsy)

Not yet recruiting
  • Prostate Cancer
  • +4 more
  • bpMRI
  • Image-Fusion targeted and systematic Biopsy
  • (no location specified)
Oct 7, 2022

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 20, 2023

Pancreatic Adenocarcinoma, Adenosquamous Carcinoma, Pancreatic Neuroendocrine Tumor Trial (ESK981)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • +6 more
  • (no location specified)
Aug 4, 2023

Prostatic Tumor, Adenocarcinoma, Tumor Recurrence Trial in Rennes, Pointe-à-Pitre (Standard care)

Recruiting
  • Prostatic Neoplasm
  • +3 more
  • Standard care
  • Rennes, Ille-et-Vilaine, France
  • +1 more
Sep 14, 2023

Prostate Cancer, Prostate Adenocarcinoma, Prostate Cancer Adenocarcinoma Trial in United States (NanoPac (sterile

Terminated
  • Prostate Cancer
  • +6 more
  • NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension
  • Tampa, Florida
  • +3 more
Mar 2, 2022

Prostatic Tumors, Castration-Resistant Trial in Brisbane ([212Pb]Pb-ADVC001)

Not yet recruiting
  • Prostatic Neoplasms
  • Castration-Resistant
  • Brisbane, Queensland, Australia
    Royal Brisbane & Women's Hospital
Feb 9, 2023

Prostate Cancer, Prostate Adenocarcinoma, Radiation Toxicity Trial in Birmingham (Stereotactic Body Radiation Therapy with

Active, not recruiting
  • Prostate Cancer
  • +3 more
  • Stereotactic Body Radiation Therapy with Integrated Boost
  • Birmingham, Alabama
    Hazelrig-Salter Radiation Oncology Center
Mar 25, 2022

Prostate Cancer, Prostate Adenocarcinoma Trial in Aurora, Denver (Ga-PSMA-11)

Active, not recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • Aurora, Colorado
  • +1 more
Jul 28, 2022

Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Scottsdale, Rochester

Active, not recruiting
  • Prostate Adenocarcinoma
  • +5 more
  • Androgen Suppression
  • +3 more
  • Scottsdale, Arizona
  • +1 more
Jan 5, 2023

Stage I Prostate Adenocarcinoma AJCC v7, Stage II Prostate Adenocarcinoma AJCC v7 Trial in Houston (Laboratory Biomarker

Active, not recruiting
  • Stage I Prostate Adenocarcinoma AJCC v7
  • Stage II Prostate Adenocarcinoma AJCC v7
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 9, 2022

Prostate Adenocarcinoma Trial in Rochester (Ulrasound Vibroelastography (UVE))

Suspended
  • Prostate Adenocarcinoma
  • Ulrasound Vibroelastography (UVE)
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 12, 2023

Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues Trial

Active, not recruiting
  • Hormone-Resistant Prostate Cancer
  • +6 more
  • Pembrolizumab
  • pTVG-HP Plasmid DNA Vaccine
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Nov 8, 2022

Prostate Adenocarcinoma Trial in Philadelphia (Niraparib Pill)

Recruiting
  • Prostate Adenocarcinoma
  • Niraparib Pill
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 29, 2022

Prostate Cancer, Prostate Adenocarcinoma, Prostate Tumor Trial (Abiraterone Oral Tablet, Prednisone tablet, Drug Dairy/Log)

Not yet recruiting
  • Prostate Cancer
  • +3 more
  • Abiraterone Oral Tablet
  • +3 more
  • (no location specified)
Apr 1, 2022

Castration-Resistant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +7 more
  • Biopsy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Metastatic Malignant Tumor in the Viscera, Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation, Metastatic

Not yet recruiting
  • Metastatic Malignant Neoplasm in the Viscera
  • +4 more
  • Lutetium Lu 177 Dotatate
  • (no location specified)
Jan 25, 2023

Metastatic Malignant Tumor in Lymph Node, Prostate Ductal Adenocarcinoma, Stage III Prostate Adenocarcinoma AJCC v7 Trial in

Active, not recruiting
  • Metastatic Malignant Neoplasm in Lymph Node
  • +3 more
  • Antiandrogen Therapy
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 3, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Adenocarcinoma Trial in

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • +5 more
  • Questionnaire Administration
  • Tin Sn 117m Pentetate
  • Lexington, Kentucky
    University of Kentucky/Markey Cancer Center
Nov 26, 2022

Prostate Adenocarcinoma, Prostate Cancer, Localized Prostate Cancer Trial in San Francisco, Saint Louis (Atezolizumab,

Recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • San Francisco, California
  • +1 more
Oct 8, 2022

Prostate Adenocarcinoma, PSA Progression, Recurrent Prostate Carcinoma Trial in Palo Alto (Gallium Ga 68 DOTA-NeoBOMB1, Gallium

Suspended
  • Prostate Adenocarcinoma
  • +2 more
  • Gallium Ga 68 DOTA-NeoBOMB1
  • Gallium Ga 68 PSMA-R2
  • Palo Alto, California
    Stanford Cancer Institute Palo Alto
May 3, 2022

Prostate Cancer, Breast Cancer, Kidney Cancer Trial in Tampere (behavioral, drug, other)

Not yet recruiting
  • Prostate Cancer
  • +11 more
  • Guided physical exercise
  • +2 more
  • Tampere, Länsi-Suomi, Finland
    Tampere University Hospital
Apr 3, 2023

Prostate Adenocarcinoma, Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage II Prostate Cancer AJCC v8

Recruiting
  • Prostate Adenocarcinoma
  • +5 more
  • Discussion
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Dec 1, 2022

Prostate Adenocarcinoma, PSA Level Greater Than Ten, Stage IIB Prostate Cancer AJCC v8 Trial in Houston (Hyperpolarized Carbon C

Active, not recruiting
  • Prostate Adenocarcinoma
  • +9 more
  • Hyperpolarized Carbon C 13 Pyruvate
  • Magnetic Resonance Spectroscopic Imaging
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2022

CT-guided Stereotactic Body Radiation Therapy and MRI-guided

Active, not recruiting
  • Prostate Adenocarcinoma
  • CT-guided Stereotactic Body Radiation Therapy
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jun 3, 2022

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Beverly Hills, Los Angeles, Pasadena

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • +5 more
  • phenelzine sulfate
  • +2 more
  • Beverly Hills, California
  • +3 more
Aug 19, 2022